 | • レポートコード：MRC2012A4103 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、胃腸OTC治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃腸OTC治療薬の種類別市場規模（下剤、抗鼓腸薬、H2-拮抗薬、止瀉薬、PPI、制吐薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Sanofi、Bayer、Pfizer、Abbott、Johnson & Johnson、Nestle、Perrigo、Procter & Gamble、Teva Pharmaceutical、Boehringer Ingelheim、Reckitt Benckiser、Purdue Pharma、 ・地域別グローバル市場分析 2015年-2020年 ・胃腸OTC治療薬の北米市場（アメリカ、カナダ、メキシコ） ・胃腸OTC治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・胃腸OTC治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・胃腸OTC治療薬の南米市場（ブラジル、アルゼンチン） ・胃腸OTC治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：下剤、抗鼓腸薬、H2-拮抗薬、止瀉薬、PPI、制吐薬、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Gastrointestinal OTC Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Gastrointestinal OTC Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gastrointestinal OTC Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gastrointestinal OTC Drugs market has been segmented into
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
By Application, Gastrointestinal OTC Drugs has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastrointestinal OTC Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastrointestinal OTC Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastrointestinal OTC Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Gastrointestinal OTC Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gastrointestinal OTC Drugs Market Share Analysis
Gastrointestinal OTC Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastrointestinal OTC Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastrointestinal OTC Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Gastrointestinal OTC Drugs are:
GlaxoSmithKline
Sanofi
Bayer
Pfizer
Abbott
Johnson & Johnson
Nestle
Perrigo
Procter & Gamble
Teva Pharmaceutical
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Among other players domestic and global, Gastrointestinal OTC Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal OTC Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastrointestinal OTC Drugs, with price, sales, revenue and global market share of Gastrointestinal OTC Drugs in 2018 and 2019.
Chapter 3, the Gastrointestinal OTC Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal OTC Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gastrointestinal OTC Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gastrointestinal OTC Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Gastrointestinal OTC Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastrointestinal OTC Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Laxatives
1.2.3 Anti-Flatulents
1.2.4 H2-Antaginists
1.2.5 Anti-Diarrheals
1.2.6 PPIs
1.2.7 Anti-Emetics
1.2.8 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastrointestinal OTC Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Overview of Global Gastrointestinal OTC Drugs Market
1.4.1 Global Gastrointestinal OTC Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Abbott SWOT Analysis
2.5.4 Abbott Product and Services
2.5.5 Abbott Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nestle
2.7.1 Nestle Details
2.7.2 Nestle Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Nestle SWOT Analysis
2.7.4 Nestle Product and Services
2.7.5 Nestle Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Perrigo
2.8.1 Perrigo Details
2.8.2 Perrigo Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Perrigo SWOT Analysis
2.8.4 Perrigo Product and Services
2.8.5 Perrigo Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Procter & Gamble
2.9.1 Procter & Gamble Details
2.9.2 Procter & Gamble Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Procter & Gamble SWOT Analysis
2.9.4 Procter & Gamble Product and Services
2.9.5 Procter & Gamble Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teva Pharmaceutical
2.10.1 Teva Pharmaceutical Details
2.10.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Teva Pharmaceutical SWOT Analysis
2.10.4 Teva Pharmaceutical Product and Services
2.10.5 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Boehringer Ingelheim SWOT Analysis
2.11.4 Boehringer Ingelheim Product and Services
2.11.5 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Reckitt Benckiser
2.12.1 Reckitt Benckiser Details
2.12.2 Reckitt Benckiser Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Reckitt Benckiser SWOT Analysis
2.12.4 Reckitt Benckiser Product and Services
2.12.5 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Purdue Pharma
2.13.1 Purdue Pharma Details
2.13.2 Purdue Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Purdue Pharma SWOT Analysis
2.13.4 Purdue Pharma Product and Services
2.13.5 Purdue Pharma Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gastrointestinal OTC Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gastrointestinal OTC Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastrointestinal OTC Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Gastrointestinal OTC Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gastrointestinal OTC Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Gastrointestinal OTC Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gastrointestinal OTC Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
4.5 South America Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gastrointestinal OTC Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Gastrointestinal OTC Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Gastrointestinal OTC Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gastrointestinal OTC Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Gastrointestinal OTC Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gastrointestinal OTC Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
6.3 UK Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
6.4 France Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gastrointestinal OTC Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gastrointestinal OTC Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gastrointestinal OTC Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
7.5 India Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gastrointestinal OTC Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Gastrointestinal OTC Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Gastrointestinal OTC Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gastrointestinal OTC Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gastrointestinal OTC Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gastrointestinal OTC Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gastrointestinal OTC Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Gastrointestinal OTC Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Gastrointestinal OTC Drugs Price by Type (2015-2020)
11 Global Gastrointestinal OTC Drugs Market Segment by Application
11.1 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
11.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Gastrointestinal OTC Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gastrointestinal OTC Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Gastrointestinal OTC Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Gastrointestinal OTC Drugs Market Forecast (2021-2025)
12.2.2 Europe Gastrointestinal OTC Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gastrointestinal OTC Drugs Market Forecast (2021-2025)
12.2.4 South America Gastrointestinal OTC Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gastrointestinal OTC Drugs Market Forecast (2021-2025)
12.3 Gastrointestinal OTC Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Gastrointestinal OTC Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Gastrointestinal OTC Drugs Market Share Forecast by Type (2021-2025)
12.4 Gastrointestinal OTC Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Gastrointestinal OTC Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Gastrointestinal OTC Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gastrointestinal OTC Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastrointestinal OTC Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Gastrointestinal OTC Drugs Major Business
Table 9. GlaxoSmithKline Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 10. GlaxoSmithKline SWOT Analysis
Table 11. GlaxoSmithKline Gastrointestinal OTC Drugs Product and Services
Table 12. GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Gastrointestinal OTC Drugs Major Business
Table 15. Sanofi Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Sanofi SWOT Analysis
Table 17. Sanofi Gastrointestinal OTC Drugs Product and Services
Table 18. Sanofi Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Gastrointestinal OTC Drugs Major Business
Table 21. Bayer Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Bayer SWOT Analysis
Table 23. Bayer Gastrointestinal OTC Drugs Product and Services
Table 24. Bayer Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Gastrointestinal OTC Drugs Major Business
Table 27. Pfizer Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Gastrointestinal OTC Drugs Product and Services
Table 30. Pfizer Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Abbott Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Gastrointestinal OTC Drugs Major Business
Table 33. Abbott Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Abbott SWOT Analysis
Table 35. Abbott Gastrointestinal OTC Drugs Product and Services
Table 36. Abbott Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 38. Johnson & Johnson Gastrointestinal OTC Drugs Major Business
Table 39. Johnson & Johnson Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Johnson & Johnson SWOT Analysis
Table 41. Johnson & Johnson Gastrointestinal OTC Drugs Product and Services
Table 42. Johnson & Johnson Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Nestle Basic Information, Manufacturing Base and Competitors
Table 44. Nestle Gastrointestinal OTC Drugs Major Business
Table 45. Nestle Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Nestle SWOT Analysis
Table 47. Nestle Gastrointestinal OTC Drugs Product and Services
Table 48. Nestle Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Perrigo Basic Information, Manufacturing Base and Competitors
Table 50. Perrigo Gastrointestinal OTC Drugs Major Business
Table 51. Perrigo Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Perrigo SWOT Analysis
Table 53. Perrigo Gastrointestinal OTC Drugs Product and Services
Table 54. Perrigo Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Procter & Gamble Basic Information, Manufacturing Base and Competitors
Table 56. Procter & Gamble Gastrointestinal OTC Drugs Major Business
Table 57. Procter & Gamble Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Procter & Gamble SWOT Analysis
Table 59. Procter & Gamble Gastrointestinal OTC Drugs Product and Services
Table 60. Procter & Gamble Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceutical Gastrointestinal OTC Drugs Major Business
Table 63. Teva Pharmaceutical Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Teva Pharmaceutical SWOT Analysis
Table 65. Teva Pharmaceutical Gastrointestinal OTC Drugs Product and Services
Table 66. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer Ingelheim Gastrointestinal OTC Drugs Major Business
Table 69. Boehringer Ingelheim Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Boehringer Ingelheim SWOT Analysis
Table 71. Boehringer Ingelheim Gastrointestinal OTC Drugs Product and Services
Table 72. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Reckitt Benckiser Basic Information, Manufacturing Base and Competitors
Table 74. Reckitt Benckiser Gastrointestinal OTC Drugs Major Business
Table 75. Reckitt Benckiser Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Reckitt Benckiser SWOT Analysis
Table 77. Reckitt Benckiser Gastrointestinal OTC Drugs Product and Services
Table 78. Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Purdue Pharma Gastrointestinal OTC Drugs Major Business
Table 81. Purdue Pharma Gastrointestinal OTC Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Purdue Pharma SWOT Analysis
Table 83. Purdue Pharma Gastrointestinal OTC Drugs Product and Services
Table 84. Purdue Pharma Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Gastrointestinal OTC Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 86. Global Gastrointestinal OTC Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Gastrointestinal OTC Drugs Sales by Regions (2015-2020) (K Pcs)
Table 88. Global Gastrointestinal OTC Drugs Sales Market Share by Regions (2015-2020)
Table 89. Global Gastrointestinal OTC Drugs Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Gastrointestinal OTC Drugs Sales by Countries (2015-2020) (K Pcs)
Table 91. North America Gastrointestinal OTC Drugs Sales Market Share by Countries (2015-2020)
Table 92. North America Gastrointestinal OTC Drugs Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Gastrointestinal OTC Drugs Revenue Market Share by Countries (2015-2020)
Table 94. Europe Gastrointestinal OTC Drugs Sales by Countries (2015-2020) (K Pcs)
Table 95. Europe Gastrointestinal OTC Drugs Sales Market Share by Countries (2015-2020)
Table 96. Europe Gastrointestinal OTC Drugs Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Gastrointestinal OTC Drugs Sales by Regions (2015-2020) (K Pcs)
Table 98. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Gastrointestinal OTC Drugs Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Gastrointestinal OTC Drugs Sales by Countries (2015-2020) (K Pcs)
Table 101. South America Gastrointestinal OTC Drugs Sales Market Share by Countries (2015-2020)
Table 102. South America Gastrointestinal OTC Drugs Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Gastrointestinal OTC Drugs Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Gastrointestinal OTC Drugs Sales by Countries (2015-2020) (K Pcs)
Table 105. Middle East & Africa Gastrointestinal OTC Drugs Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Gastrointestinal OTC Drugs Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Gastrointestinal OTC Drugs Revenue Market Share by Countries (2015-2020)
Table 108. Global Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 109. Global Gastrointestinal OTC Drugs Sales Share by Type (2015-2020)
Table 110. Global Gastrointestinal OTC Drugs Revenue by Type (2015-2020) (USD Million)
Table 111. Global Gastrointestinal OTC Drugs Revenue Share by Type (2015-2020)
Table 112. Global Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 113. Global Gastrointestinal OTC Drugs Sales Share by Application (2015-2020)
Table 114. Global Gastrointestinal OTC Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 115. Global Gastrointestinal OTC Drugs Market Share Forecast by Regions (2021-2025)
Table 116. Global Gastrointestinal OTC Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 117. Global Gastrointestinal OTC Drugs Market Share Forecast by Type (2021-2025)
Table 118. Global Gastrointestinal OTC Drugs Sales Forecast by Application (2021-2025)
Table 119. Global Gastrointestinal OTC Drugs Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gastrointestinal OTC Drugs Picture
Figure 2. Global Sales Market Share of Gastrointestinal OTC Drugs by Type in 2019
Figure 3. Laxatives Picture
Figure 4. Anti-Flatulents Picture
Figure 5. H2-Antaginists Picture
Figure 6. Anti-Diarrheals Picture
Figure 7. PPIs Picture
Figure 8. Anti-Emetics Picture
Figure 9. Other Picture
Figure 10. Gastrointestinal OTC Drugs Sales Market Share by Application in 2018
Figure 11. Hospital Pharmacies Picture
Figure 12. Retail Pharmacies Picture
Figure 13. Online Pharmacies Picture
Figure 14. Global Gastrointestinal OTC Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Gastrointestinal OTC Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturer in 2019
Figure 35. Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Gastrointestinal OTC Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Gastrointestinal OTC Drugs Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Gastrointestinal OTC Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Gastrointestinal OTC Drugs Revenue Market Share by Regions (2015-2020)
Figure 42. Global Gastrointestinal OTC Drugs Revenue Market Share by Regions in 2018
Figure 43. North America Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
Figure 44. Europe Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
Figure 46. South America Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020)
Figure 48. North America Gastrointestinal OTC Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Gastrointestinal OTC Drugs Sales Market Share by Countries (2015-2020)
Figure 50. North America Gastrointestinal OTC Drugs Sales Market Share by Countries in 2018
Figure 51. North America Gastrointestinal OTC Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Gastrointestinal OTC Drugs Revenue Market Share by Countries in 2018
Figure 53. United States Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Gastrointestinal OTC Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Gastrointestinal OTC Drugs Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Gastrointestinal OTC Drugs Revenue Market Share by Countries in 2019
Figure 59. Germany Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Gastrointestinal OTC Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Gastrointestinal OTC Drugs Revenue Market Share by Regions 2019
Figure 67. China Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Gastrointestinal OTC Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Gastrointestinal OTC Drugs Sales Market Share by Countries in 2019
Figure 74. South America Gastrointestinal OTC Drugs Revenue Market Share by Countries in 2019
Figure 75. Brazil Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Gastrointestinal OTC Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Gastrointestinal OTC Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Gastrointestinal OTC Drugs Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Gastrointestinal OTC Drugs Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Gastrointestinal OTC Drugs Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Gastrointestinal OTC Drugs Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Gastrointestinal OTC Drugs Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
胃腸OTC薬の世界市場（～2026年） Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC…- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 胃腸治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Gastrointestinal Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.8% in the forecast period of 2020 to 2025 and will expected to reach USD 36210 million by 2025, from USD 35130 million in 2019. The Gastrointestina…
- 抗ニキビ薬の世界市場（～2026年） Market Analysis and Insights: Global Anti Acne Drugs Market The global Anti Acne Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti Acne Drugs Scope and Market Size Anti Acne Drugs market is segmented by Type, …
- 抗高血圧薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-Hypertensive Drugs Market The global Anti-Hypertensive Drugs market size is projected to reach US$ 40970 million by 2026, from US$ 40270 million in 2020, at a CAGR of 1.6%% during 2021-2026. Global Anti-Hypertensive Drugs Scope and Market Size Anti-Hypertens…